The Hygieia In Silico Platform Master Monograph: Quantitative Systems Pharmacology Engine, Multi-System Clinical Validation Across 6 Landmark Human Trials, and 3,571-Year Combinatorial Discovery Library
Year: 2026
Type: article
Abstract: Comprehensive master technical monograph documenting The Hygieia Platform v2.1 under ASME V&V 40 (2018) computational modeling standards. Integrates an unparameterized European adult male reference physiology (73 kg, stiff Radau IIA differential ODE solver) across 21,742 unique combinatorial simulations, compiling 1,304,520 simulated patient-days (3,571.58 biological years, dating back to ~1545 BC) and 2,587 compiled APA PDF research monographs. Details prospective replication of six landmark human randomized controlled trials without retrospective tuning: (1) GlyNAC (Kumar et al., 2021, 2023, Baylor College of Medicine); (2) Sinclair NMN + Resveratrol Regimen (Baur & Sinclair, 2006; Walle, 2011, Harvard); (3) Quadruple Redox-Sirtuin Matrix; (4) Curcumin + Piperine (Shoba et al., 1998; Panahi et al., 2015); (5) Caffeine + L-Theanine (Haskell et al., 2008; Owen et al., 2008; Kelly et al., 2008); and (6) Berberine + Silymarin (Di Pierro et al., 2012, 2013; Guarino et al., 2017). Outlines the Sweet Spot Inversion Phenomenon, 8 secondary cellular adaptation pathways, multi-tiered IP protection, and formulation patent claim boundaries.
Author: Lanzett, Harri
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7225466836